References
Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133–1140
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79
Buchan AM, Lin CY, Choi J, Barber DL (2002) Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration. J Biol Chem 277:28431–28438
Callaghan B, Furness JB (2014) Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds. Pharmacol Rev 66:984–1001
Cervia D, Casini G, Bagnoli P (2008) Physiology and pathology of somatostatin in the mammalian retina: a current view. Mol Cell Endocrinol 286:112–122
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM (2012) Pasireotide B2305 Study Group. A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med 366:914–924
Conlon JM, Tostivint H, Vaudry H (1997) Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul Pept 69:95–103
Córdoba-Chacón J, Gahete MD, Durán-Prado M, Luque RM, Castaño JP (2011) Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology. Ann N Y Acad Sci 1220:6–15
Cuevas-Ramos D, Carmichael JD, Cooper O, Bonert VS, Gertych A, Mamelak AN, Melmed S (2015) A structural and functional acromegaly classification. J Clin Endocrinol Metab 100:122–131
de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CLM, Siggins GR, Henriksen SJ, Sutcliffe JG (1996) A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242–245
Durán-Prado M, Gahete MD, Martínez-Fuentes AJ, Luque RM, Quintero A, Webb SM, Benito-López P, Leal A, Schulz S, Gracia-Navarro F et al (2009) Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab 94:2634–2643
Ensinck JW, Baskin DG, Vahl TP, Vogel RE, Laschansky EC, Francis BH, Hoffman RC, Krakover JD, Stamm MR, Low MJ et al (2002) Thrittene, homologous with somatostatin-28((1-13)), is a novel peptide in mammalian gut and circulation. Endocrinology 143:2599–2609
Ensinck JW, Laschansky EC, Vogel RE, D’Alessio DA (2003) Effect of ingested nutrients on the release of thrittene into the human circulation. J Clin Endocrinol Metab 88:4798–4804
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK et al (2014) Pasireotide C2402 Study Group. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet Diabetes Endocrinol 2:875–884
Gatto F, Feelders RA, Franck SE, van Koetsveld PM, Dogan F, Kros JM, Neggers SJCMM, van der Lely A-J, Lamberts SWJ, Ferone D et al (2017) In vitro head-to-head comparison between octreotide and pasireotide in GH-secreting pituitary adenomas. J Clin Endocrinol Metab 102:2009–2018
Giustina A, Mazziotti G, Torri V, Spinello M, Floriani I, Melmed S (2012) Metaanalysis on the effects of octreotide on tumor mass in acromegaly. PLoS One 7:e36411
Gunther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castano JP, Wester HJ, Culler M, Melmed S, Schulz S (2018) International union of basic and clinical pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature. Pharmacol Rev 70:763–835
Heiman ML, Murphy WA, Coy DH (1987) Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. Neuroendocrinology 45:429–436
Johansson O, Hökfelt T, Elde RP (1984) Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13:265–339
Kreienkamp H-J, Roth A, Richter D (1998) Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Cell Biol 17:869–878
Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC, Lamberts SWJ (1989) Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1:242–244
Lehmann A, Kliewer A, Schütz D, Nagel F, Stumm R, Schulz S (2014) Carboxylterminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor. Mol Cell Endocrinol 387:44–51
Lehmann A, Kliewer A, Günther T, Nagel F, Schulz S (2016) Identification of phosphorylation sites regulating sst3 somatostatin receptor trafficking. Mol Endocrinol 30:645–659
Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S (2009) Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab 94:654–661
Liu Y, Lu D, Zhang Y, Li S, Liu X, Lin H (2010) The evolution of somatostatin in vertebrates. Gene 463:21–28
Müller EE, Locatelli V, Cocchi D (1999) Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511–607
Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201–17210
Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W (2004) Regulation and function of somatostatin receptors. J Neurochem 89:1057–1091
Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198
Peineau S, Potier B, Petit F, Dournaud P, Epelbaum J, Gardette R (2003) AMPAsst2 somatostatin receptor interaction in rat hypothalamus requires activation of NMDA and/or metabotropic glutamate receptors and depends on intracellular calcium. J Physiol 546:101–117
Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S (2013) Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. Mol Endocrinol 27:671–682
Peverelli E, Mantovani G, Calebiro D, Doni A, Bondioni S, Lania A, Beck-Peccoz P, Spada A (2008) The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation. Mol Endocrinol 22:676–688
Pfeiffer M, Koch T, Schröder H, Klutzny M, Kirscht S, Kreienkamp H-J, Höllt V, Schulz S (2001) Homo- and heterodimerization of somatostatin receptor subtypes: inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027–14036
Pfeiffer M, Koch T, Schröder H, Laugsch M, Höllt V, Schulz S (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 277:19762–19772
Rai U, Thrimawithana TR, Valery C, Young SA (2015) Therapeutic uses of somatostatin and its analogues: current view and potential applications. Pharmacol Ther 152:98–110
Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC (2000a) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154–157
Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC (2000b) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862–7869
Roth A, Kreienkamp H-J, Meyerhof W, Richter D (1997) Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. J Biol Chem 272:23769–23774
Samson WK, Zhang JV, Avsian-Kretchmer O, Cui K, Yosten GLC, Klein C, Lyu R-M, Wang YX, Chen XQ, Yang J et al (2008) Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions. J Biol Chem 283:31949–31959
Schreff M, Schulz S, Händel M, Keilhoff G, Braun H, Pereira G, Klutzny M, Schmidt H, Wolf G, Höllt V (2000) Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. J Neurosci 20:3785–3797
Schulz S, Lehmann A, Kliewer A, Nagel F (2014) Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR review 5. Br J Pharmacol 171:1591–1599
Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D (2008) Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol 286:26–34
Smalley KSM, Koenig JA, Feniuk W, Humphrey PPA (2001) Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst(4)) receptors expressed in CHO-K1 cells. Br J Pharmacol 132:1102–1110
Spier AD, de Lecea L (2000) Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 33:228–241
Stengel A, Karasawa H, Taché Y (2015) The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior. Horm Behav 73:15–22
Stroh T, Jackson AC, Sarret P, Dal Farra C, Vincent JP, Kreienkamp HJ, Mazella J, Beaudet A (2000) Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis. Endocrinology 141:354–365
Tulipano G, Schulz S (2007) Novel insights in somatostatin receptor physiology. Eur J Endocrinol 156(Suppl 1):S3–S11
Tulipano G, Stumm R, Pfeiffer M, Kreienkamp H-J, Höllt V, Schulz S (2004) Differential b-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279:21374–21382
Urban-Ciecko J, Barth AL (2016) Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci 17:401–409
Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J (2008) Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol 286:75–87
Vockel M, Breitenbach U, Kreienkamp H-J, Brandner JM (2010) Somatostatin regulates tight junction function and composition in human keratinocytes. Exp Dermatol 19:888–894
Vockel M, Pollok S, Breitenbach U, Ridderbusch I, Kreienkamp H-J, Brandner JM (2011) Somatostatin inhibits cell migration and reduces cell counts of human keratinocytes and delays epidermal wound healing in an ex vivo wound model. PLoS One 6:e19740
Yosten GLC, Elrick MM, Salvatori A, Stein LM, Kolar GR, Ren J, Corbett JA, Samson WK (2015) Understanding peptide biology: the discovery and characterization of the novel hormone, neuronostatin. Peptides 72:192–195
Zhao P, Canals M, Murphy JE, Klingler D, Eriksson EM, Pelayo JC, Hardt M, Bunnett NW, Poole DP (2013) Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons. J Biol Chem 288:25689–25700
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag Berlin Heidelberg New York
About this entry
Cite this entry
Tulipano, G., Schulz, S. (2021). Somatostatin. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_137-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-21573-6_137-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21573-6
Online ISBN: 978-3-030-21573-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences